Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG and alternative intravesical protocols for NMIBC
ChiCTR-IIR-16008357Phase 4Recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- May 2015
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bcg vaccine and epirubicin in bladder cancer (3 arms), sponsored by Sun Yat-sen Memorial Hospital. Started May 2015; status: recruiting.
02
Drugs
bcg vaccineepirubicin
03
Conditions
bladder cancer
Beyond the preview
Go deeper on ChiCTR-IIR-16008357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IIR-16008357.